Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Factors affecting bone strength other than osteoporosis.

Ratti C, Vulcano E, Canton G, Marano M, Murena L, Cherubino P.

Aging Clin Exp Res. 2013 Oct;25 Suppl 1:S9-11. doi: 10.1007/s40520-013-0098-6. Epub 2013 Sep 18. Review.

PMID:
24046057
2.

Diseases affecting bone quality: beyond osteoporosis.

Unnanuntana A, Rebolledo BJ, Khair MM, DiCarlo EF, Lane JM.

Clin Orthop Relat Res. 2011 Aug;469(8):2194-206. doi: 10.1007/s11999-010-1694-9. Review.

4.

[Bone fragility].

Poursac N, Mehsen-CĂȘtre N, Bannwarth B.

Rev Prat. 2014 Mar;64(3):425-32. Review. French. No abstract available.

PMID:
24851381
5.

A new antiresorptive approach to the treatment of fragility fractures: long-term efficacy and safety of denosumab.

Tarantino U, Celi M, Feola M, Liuni FM, Resmini G, Iolascon G.

Aging Clin Exp Res. 2013 Oct;25 Suppl 1:S65-9. doi: 10.1007/s40520-013-0082-1. Epub 2013 Sep 18. Review.

PMID:
24046047
6.

Unresolved issues in osteoporosis in men.

Seeman E.

Rev Endocr Metab Disord. 2001 Jan;2(1):45-64. Review.

PMID:
11704979
7.

Osteodensitometry in healthy postmenopausal women.

[No authors listed]

Prescrire Int. 2008 Apr;17(94):68-72.

PMID:
18536138
8.

Aging and strength of bone as a structural material.

Martin B.

Calcif Tissue Int. 1993;53 Suppl 1:S34-9; discussion S39-40. Review.

PMID:
8275378
9.
10.

Low handgrip strength is associated with low bone mineral density and fragility fractures in postmenopausal healthy Korean women.

Kim SW, Lee HA, Cho EH.

J Korean Med Sci. 2012 Jul;27(7):744-7. doi: 10.3346/jkms.2012.27.7.744. Epub 2012 Jun 29.

11.

Bone resorption and osteoporotic fractures in elderly men: the dubbo osteoporosis epidemiology study.

Meier C, Nguyen TV, Center JR, Seibel MJ, Eisman JA.

J Bone Miner Res. 2005 Apr;20(4):579-87. Epub 2004 Dec 6.

12.

Postmenopausal osteoporosis: the role of immune system cells.

Faienza MF, Ventura A, Marzano F, Cavallo L.

Clin Dev Immunol. 2013;2013:575936. doi: 10.1155/2013/575936. Epub 2013 May 23. Review.

13.

The bone anabolic therapy.

Nardi A, Ventura L, Cozzi L, Tonini G, Zennaro R, Celi M, Ramazzina E.

Aging Clin Exp Res. 2013 Oct;25 Suppl 1:S121-4. Epub 2013 Sep 28.

PMID:
24078441
14.

Mechanisms of impaired bone strength in type 1 and 2 diabetes.

Merlotti D, Gennari L, Dotta F, Lauro D, Nuti R.

Nutr Metab Cardiovasc Dis. 2010 Nov;20(9):683-90. doi: 10.1016/j.numecd.2010.07.008. Review.

PMID:
20934862
15.

Office practice of osteoporosis evaluation.

Lacativa PG, de Farias ML.

Arq Bras Endocrinol Metabol. 2006 Aug;50(4):674-84. Review.

16.

[Outline of Guidelines 2004 for bone marker in osteoporosis].

Nishizawa Y.

Nihon Rinsho. 2007 Nov 28;65 Suppl 9:37-41. Review. Japanese. No abstract available.

PMID:
18161079
17.

Pathophysiology of osteoporosis and fracture.

Lappe JM.

Nurs Clin North Am. 2001 Sep;36(3):393-400, vii. Review.

PMID:
11532654
18.

Gender and osteoporosis: similarities and sex-specific differences.

Boling EP.

J Gend Specif Med. 2001;4(2):36-43. Review.

PMID:
11480096
19.

Bone quality: what is it and how is it measured?

Compston J.

Arq Bras Endocrinol Metabol. 2006 Aug;50(4):579-85. Review.

20.

Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review.

Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE.

Osteoporos Int. 2004 Oct;15(10):767-78. Epub 2004 Jul 16. Review.

PMID:
15258724
Items per page

Supplemental Content

Write to the Help Desk